View Older Stories View More Recent Stories

Nov 27, 2018 07:30AM Arrowhead Pharmaceuticals to Webcast 2018 Fiscal Year End Results
Nov 9, 2018 12:00PM Arrowhead Pharma (ARWR) Presents Late-Breaking Preliminary Clinical Data on ARO-HBV at Liver Meeting
Nov 9, 2018 12:00PM Arrowhead Pharmaceuticals Presents Late-Breaking Clinical Data on ARO-AAT at Liver Meeting® 2018
Nov 9, 2018 12:00PM Arrowhead Pharmaceuticals Presents Late-Breaking Preliminary Clinical Data on ARO-HBV at Liver Meeting® 2018
Nov 1, 2018 07:30AM Arrowhead Pharmaceuticals to Present at Upcoming November 2018 Conferences
Oct 31, 2018 07:30AM Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen
Oct 16, 2018 12:01PM Arrowhead Pharmaceuticals Hosts R&D Day on Pipeline of RNAi Therapeutics
Oct 15, 2018 07:31AM Arrowhead Pharmaceuticals Corp (ARWR) Reports Filing for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3
Oct 15, 2018 07:30AM Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3
Oct 11, 2018 12:08PM Arrowhead Pharmaceuticals Corp (ARWR) to Present Late-Breaking Clinical Data on ARO-AAT and ARO-HBV at AASLD
Oct 11, 2018 12:05PM Arrowhead to Present Late-Breaking Clinical Data on ARO-AAT and ARO-HBV at AASLD Liver Meeting® 2018
Oct 4, 2018 07:32AM Arrowhead (ARWR) Announces $3.7 Billion License and Collaboration Agreements with Janssen (JNJ)
Oct 4, 2018 07:30AM Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen
Sep 25, 2018 07:30AM Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences
Sep 24, 2018 07:30AM Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics
Sep 21, 2018 04:00PM Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Sep 6, 2018 09:17AM Arrowhead Pharmaceuticals Corp (ARWR) to Present Positive ARO-HBV Clinical Data Demonstrating HBsAg Reductions
Sep 6, 2018 07:30AM Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit
Aug 31, 2018 07:31AM Arrowhead Pharmaceuticals Corp (ARWR) Reports Complete Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Aug 31, 2018 07:30AM Arrowhead Completes Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Aug 30, 2018 04:00PM Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences
Aug 7, 2018 04:00PM Arrowhead Pharmaceuticals Reports Fiscal 2018 Third Quarter Results
Aug 1, 2018 07:40AM Arrowhead Pharmaceuticals (ARWR) Reports $10 Million Milestone Payment from Amgen
Aug 1, 2018 07:30AM Arrowhead Pharmaceuticals Earns $10 Million Milestone Payment from Amgen
Jul 24, 2018 07:30AM Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Third Quarter Results
Jun 29, 2018 07:31AM Arrowhead Pharmaceuticals Corp (ARWR) Highlights New Clinical Data on ARO-AAT at Alpha-1 National Education Conference
Jun 29, 2018 07:30AM Arrowhead Presents New Clinical Data on ARO-AAT at Alpha-1 National Education Conference
Jun 27, 2018 07:33AM Arrowhead Pharmaceuticals Corp (ARWR) Granted Positive EMA Opinion on Orphan Designation for ARO-AAT for Treatment of Congenital Alpha-1 Antitrypsin Deficiency
Jun 27, 2018 07:30AM Arrowhead Receives Positive EMA Opinion on Orphan Designation for ARO-AAT for Treatment of Congenital Alpha-1 Antitrypsin Deficiency
Jun 18, 2018 07:30AM Arrowhead Pharmaceuticals Corp (ARWR) Announces Complete Enrollment in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Jun 18, 2018 07:30AM Arrowhead Completes Enrollment in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Jun 8, 2018 04:30PM Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
May 30, 2018 07:39AM Arrowhead Pharmaceuticals Corp (ARWR) Reports Complete Enrollment in Single Dose Portion of Phase 1/2 Study of ARO-HBV
May 30, 2018 07:30AM Arrowhead Completes Enrollment in Single Dose Portion of Phase 1/2 Study of ARO-HBV
May 30, 2018 07:25AM Arrowhead Pharmaceuticals to Present at Upcoming June 2018 Conferences
May 21, 2018 07:30AM Arrowhead Pharmaceuticals Presents New Preclinical Data on ARO-ENaC for Treatment of Cystic Fibrosis
May 14, 2018 07:34AM Arrowhead Pharmaceuticals Corp (ARWR) Reports Dosing of 1st Hepatitis B Patient in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV
May 14, 2018 07:30AM Arrowhead Doses First Hepatitis B Patients in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV
May 11, 2018 07:30AM Arrowhead Pharmaceuticals Presents Preclinical Data on Expanding Cardiometabolic Pipeline
May 8, 2018 04:00PM Arrowhead Pharmaceuticals Reports Fiscal 2018 Second Quarter Results
May 1, 2018 07:30AM Arrowhead Pharmaceuticals to Present Preclinical Data on Emerging Pipeline of RNAi Therapeutics
Apr 24, 2018 04:01PM Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Second Quarter Results
Apr 11, 2018 07:06AM Arrowhead Pharmaceuticals Corp (ARWR) Announces Clinical Data on ARC-520 at International Liver Congress 2018
Apr 11, 2018 07:00AM Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™
Mar 28, 2018 07:32AM Arrowhead Pharmaceuticals Corp (ARWR) Announces Multiple Presentations at The International Liver Congress
Mar 28, 2018 07:30AM Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress™
Mar 27, 2018 07:34AM Arrowhead Pharmaceuticals Corp (ARWR) Commences Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
Mar 27, 2018 07:30AM Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
Mar 20, 2018 04:05PM Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Mar 12, 2018 07:30AM Arrowhead Begins Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
View More Recent Stories View Older Stories